Satsuma Pharmaceuticals OverviewSatsuma Pharmaceuticals Research & Development
Research & Development expenses for STSA.
Quarterly R&D Expenses
$7.46M
↓ 35.45% YoY
As of Mar 31, 2023
Annual R&D Expenses (TTM)
$39.99M
↓ 4.85% YoY
Trailing 12 months ending Mar 31, 2023